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ATP-dependent unwinding of U4/U6 snRNAs by the Brr2 
helicase requires the C-terminus of Prp8
Corina Maeder1,3, Alan K. Kutach1,2,3, and Christine Guthrie1
1Department of Biochemistry and Biophysics, University of California, San Francisco, 600 16th 
Street, Genentech Hall, San Francisco, CA 94143, USA
Summary
The spliceosome is a highly dynamic machine requiring multiple RNA-dependent ATPases of the 
DExD/H-box family. A fundamental unanswered question is how their activities are regulated. 
Brr2 function is necessary for unwinding the U4/U6 duplex, a step essential for catalytic activation 
of the spliceosome. Here we show that Brr2-dependent dissociation of U4/U6 snRNAs in vitro is 
activated by a fragment from the C-terminus of the U5 snRNP protein Prp8. In contrast to its 
helicase-stimulating activity, this fragment inhibits Brr2 U4/U6-dependent ATPase activity. 
Notably, U4/U6 unwinding activity is not stimulated by fragments carrying alleles of prp8 that in 
humans confers an autosomal dominant form of retinitis pigmentosa. Because Brr2 activity must 
be restricted to prevent premature catalytic activation, our results have important implications for 
fidelity maintenance in the spliceosome.
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Introduction
The spliceosome is a highly dynamic RNA-protein machine requiring the ordered binding 
and release of 5 small nuclear ribonucleoprotein particles (snRNPs) to the intron-containing 
pre-mRNA1. Following recognition of the 5′ splice site by base-pairing to U1 snRNA and 
the intron branchpoint sequence by base-pairing to U2 snRNA, the U4/U6.U5 triple snRNP 
complex joins the assembling spliceosome. In this complex, U4 snRNA is extensively base-
paired to U6 snRNA. Despite the presence of all 5 essential snRNAs, this form of the 
spliceosome is catalytically inactive; the two sequential trans-esterification reactions require 
the unwinding of U4 from U6 and the coordinated release of U1 snRNP. This strategy 
presumably ensures that catalytic activation is restricted until the appropriate intronic signals 
have been accurately identified. After the completion of the chemical steps, the spliceosome 
disassembles and the snRNPs must be recycled for the next round.
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Aside from the binding of the U1 snRNP to the 5′ splice site, each step in this dynamic cycle 
requires ATP and one or more DExD/H RNA-dependent ATPases, a large protein family 
whose members share a ∼300 amino acid domain with eight highly conserved sequence 
motifs2,3. The founding member of this family is eIF4A, a DEAD-box protein that is 
thought to use the energy of ATP hydrolysis to unwind base-paired RNAs4. In other cases, 
the ATPases are thought to promote the displacement of proteins from a bound RNA2,3. In 
budding yeast, eight DExD/H-box proteins are required for splicing: Sub2, Prp5, Brr2, Prp2, 
Prp28, Prp16, Prp22 and Prp43 (ref. 1). Several of these RNA-dependent ATPases have 
been shown to possess weak in vitro RNA unwinding activity5-11; in the case of Prp43, this 
activity has been shown to be stimulated by a protein co-factor, Ntr1(ref. 10). Further 
progress has been hindered by the absence of precise information about the targeted 
rearrangements. Since several of these DExD/H-box proteins have been shown to play an 
important role in fidelity maintenance12-16, an understanding of how their activities are 
timed is of crucial importance.
Many of the DExD/H-box proteins have been shown to be only transiently associated with 
the spliceosome and their regulation might thus be accounted for, at least in part, by the 
timing of their associations1. In contrast, Brr2 is an integral component of the U5 snRNP, 
where it is tightly complexed with Prp8 and Snu114. Brr2 is an atypical family member in 
that it contains two helicase-like domains17,18. The C-terminal domain differs substantially 
from consensus motifs and several mutations failed to confer a biological phenotype19. The 
N-terminal domain contains a canonical DEIH-box motif and a mutation in the ATP binding 
region of the budding yeast protein confers a cold-sensitive growth phenotype20. Notably, 
the brr2-1 allele, a mutation in the N-terminal DEIH-box motif, eliminates the ATP-
dependent unwinding of U4 from U6 in vitro21. The human Brr2 protein has been shown to 
unwind U4/U6 duplexes in vitro, but this reaction required a large excess of protein to RNA 
and long incubation times6.
Unwinding of U4 from U6 is essential for the catalytic activation of the spliceosome to 
allow the re-folding of U6 with U2 snRNA22. Moreover, it has recently been shown that 
Brr2 must function again at the end of the cycle, in this case to promote dissociation of U2 
from U6 (ref. 23). Thus the regulation of Brr2 activity must be central to the fidelity of 
splicing, to ensure that neither catalytic activation nor spliceosome disassembly is 
premature. Both of these Brr2-dependent steps also require the function of Snu114, an EF2-
like GTPase23,24. Extensive genetic and biochemical evidence has also implicated Prp8 in 
the function of Brr2 and Snu114 (reviewed in refs. 25,26). In particular, both the ATPase 
and the GTPase interact with the N and C termini of Prp8 (refs. 27-29), itself the largest 
protein in the spliceosome. Interestingly, the C-terminal region of Prp8 contains a 
Jab1/MPN domain26 which interacts with ubiquitin in vitro30 although it lacks the catalytic 
residue required for deubiquitinase function. As shown in recent crystal structures of the 
∼300 C-terminal amino acids of human and yeast Prp8, the N- and C-terminal extensions of 
the Jab1/MPN motifs form alpha helices that wrap around the compact core28,29. 
Remarkably, the very C-terminus forms an unstructured tail that contains the sites of 16 
independent mutations that lead to the onset of retinitis pigmentosa (RP), a degenerative eye 
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disease31,32. The introduction of several RP alleles into budding yeast Prp8 weakened 2-
hybrid and co-immunoprecipitation interactions with Brr2 (ref. 32).
Here we show that a ∼600 amino acid region from the C-terminus of Prp8 interacted with 
full-length Brr2 and efficiently stimulated its ATP-dependent unwinding of a synthetic 
U4/U6 duplex in Saccharomyces cerevisiae. This stimulation was lost or substantially 
weakened when the Prp8 fragment contains an RP mutation, even when interaction of Brr2 
with Prp8 was not substantially reduced. Interestingly, in contrast to its stimulation of Brr2 
helicase activity, the wild-type Prp8 fragment actually inhibited the RNA-dependent ATPase 
activity of Brr2. These results suggest that Prp8 regulates the timing of unwinding activity of 
Brr2.
Results
Prp8-CTF interacts with Brr2 in vitro
While little is known about the domain structure of Prp8, genetic and yeast two-hybrid 
studies have shown that both the N- and C-termini of Prp8 interact with Brr2 (ref. 33). To 
determine whether the interaction between the C-terminal region of Prp8 and Brr2 is direct, 
we performed binding assays between Prp8 and Brr2. To isolate fragments of the insoluble 
2413 amino acid Prp8 for biochemical studies, we performed protease hypersensitivity 
mapping to determine discrete domain boundaries (Supplementary Fig. 1). Using our 
defined fragments, we were able to express and purify from E. coli a soluble, recombinant 
607 amino acid fragment of Prp8 (1806-2413 aa) N-terminally tagged with glutathione-S-
transferase (GST) (Prp8-CTF). Prp8-CTF encompasses the RNase H and Jab1/MPN 
domains (Fig. 1A). Recent crystal structures for the N-terminal half of our fragment 
determined a β-finger domain surrounded by an RNase H domain, which lacks its active site 
residues34-36 and the C-terminal half of our fragment confirmed the presence of a Jab1/
MPN-like fold28,29.
In order to examine the interaction between Prp8-CTF and Brr2, we performed GST-pull 
down experiments of Prp8-CTF and full-length Brr2, which was purified from S. cerevisiae 
overexpressing TAP-tagged Brr2 (ref. 37). We purified Brr2 under high salt conditions (750 
mM NaCl) in order to disrupt interactions with spliceosomal proteins. Western blotting of 
1μg of purified Brr2 failed to detect either of the U5 snRNP proteins Prp8 or Snu114. Brr2 
was able to specifically associate with Prp8-CTF and not GST alone (Fig. 1B) in this 
purified system under lower salt conditions, demonstrating a direct interaction between these 
proteins, as previously observed by yeast two-hybrids, co-immunoprecipitation, and 
genetics33. Additionally, Brr2 harboring the brr2-1 helicase domain mutation20 was able to 
associate with Prp8-CTF to the same extent, indicating that the interactions between these 
proteins is not affected by this mutation (Fig. 1B).
RP mutations effects growth and interactions with Brr2
Several mutations that are linked to the human degenerative eye disease RP are located in 
Prp8-CTF in a region C-terminal to the Jab1/MPN domain (Fig. 1A). In vitro splicing 
defects were found for several of the mutations32 suggesting that they are disruptive to the 
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splicing machinery. To determine the effects of these RP mutations on viability, we 
introduced plasmid-borne wild-type and RP-mutant versions of full-length PRP8 to a strain 
in which the chromosomal copy of PRP8 has been deleted. We observed a range of growth 
phenotypes for the series of alleles (Fig. 2A). As seen previously, strains containing 2 of the 
5 alleles (H2387P and H2387R) are dead or severely sick at higher temperatures32.
To compare the effects on growth with the effects on Prp8′s interactions with Brr2, we 
introduced the series of five RP mutations into our Prp8-CTF constructs. We were able to 
express and purify soluble recombinant Prp8-CTF mutant proteins from E. coli. However, 
the yield of the H2387P and H2387R mutant fragments was approximately ten times lower 
than the wild-type fragment suggesting that these fragments are less soluble or stable than 
the wild-type fragment. We then examined their ability to directly interact with Brr2 using 
our GST-pulldown interaction assay (Fig. 2B). Equimolar amounts of proteins are used in all 
interaction assays. In order to illustrate the hierarchy of Brr2 binding seen among the Prp8 
RP mutants, we are showing the wild-type signal for Prp8 at saturation.
Although the strains with F2382L, R2388G or R2388K mutant versions of PRP8 grew 
similarly to the wild type, we see weakened interactions of the corresponding mutant Prp8-
CTFs with Brr2. However, H2387P or H2387R mutations in PRP8 strains behaved quite 
differently. The prp8-H2387P mutant displayed slightly reduced growth at 30°C, and 
extreme sickness at 37°C. The prp8-H2387R mutant was extremely sick at 30°C, and 
inviable at 37°C. For both of these mutations, we observe only background level of Brr2 
binding. These findings indicate the RP region of yeast Prp8 is important for Prp8′s 
function. The most severe growth phenotype corresponds with the most severe Prp8-CTF-
Brr2 interaction defect, but this does not rule out that the RP mutations result in phenotypes 
due to loss of some other function (see below).
The fact that mutations resulting in no interaction between Brr2 and Prp8-CTF in vitro are 
viable at all suggests one of two possibilities. First, the in vivo interaction is not essential for 
cell viability. Second, although our in vitro interaction assay does not detect binding of Brr2 
to Prp8-CTF with either H2387 mutation, a more likely possibility is that the mutants retain 
some affinity for Brr2 in vivo. In support of the latter scenario, we have observed that 
addition of a C-terminal epitope tag to PRP8 exacerbates some of the RP-mutant phenotypes 
observed in yeast, although it has no effect on growth in a wild-type strain (data not shown 
and ref. 32). With an epitope tag, the H2387 mutants are inviable, and both of the R2388 
mutants display temperature sensitivity. This is notable in light of the finding that one of the 
characterized RP mutations in humans results in conversion of stop codon to leucine, 
resulting in a 41 amino acid extension of the Prp8 polypeptide38, further suggesting that 
inserting an epitope tag at the C-terminus of Prp8 is akin to introducing an RP mutation.
Prp8-CTF stimulates Brr2′s helicase activity
Genetic interaction studies have suggested that Prp8 negatively regulates Brr2-dependent 
RNA unwinding events during the splicing cycle39,40. Having established a direct 
interaction between Prp8-CTF and Brr2, we wanted to investigate what effect this 
interaction may have on Brr2′s intrinsic dsRNA helicase and RNA-dependent ATP 
hydrolysis activities. Because other studies suggest that U4/U6 snRNA is a native substrate 
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of Brr2 (refs. 6, 21), we also chose to use U4/U6 snRNAs as a substrate in our unwinding 
assays.
U4 and U6 snRNAs were transcribed from a T7 promoter, purified and freshly annealed in 
the presence of Mg++ prior to each experiment. In addition to a full-length U6, we used a 
synthetic U6 snRNA (U6syn) containing nucleotides 22-112 (Fig. 3A), because the first 21 
nucleotides of U6 have been shown to be dispensable for splicing in vitro41. After observing 
that full-length U6 and our U6syn behaved identically in our experiments (data not shown), 
we used U6syn for our remaining assays. Brr2 (25nM) and Prp8-CTF (250 nM) were 
combined with hybridized snRNAs (200nM) and pre-incubated at 30°C (see Materials and 
Methods). Helicase reactions were initiated by addition of ATP and then incubated at 30°C 
for the course of the reaction. At the time indicated, samples from each reaction condition 
were withdrawn and helicase activity halted by the addition of excess EDTA to chelate 
Mg++ ions (Fig. 3B). Unwound RNAs were separated by native gel electrophoresis and U4 
snRNA was detected by a fluorescently labeled anti-U4 snRNA oligonucleotide42.
We first examined the ability of purified Brr2 alone to unwind U4/U6 snRNAs (Fig. 3b,c) in 
our in vitro system. Over the course of one hour we observed less than 20% of U4/U6 
unwound to U4 and U6 (Fig. 3B). This is consistent with Laggerbauer et al. who showed 
that the reaction is not particularly efficient since a 100:1 ratio of enzyme:substrate 
incubated for one hour at 40°C does not completely unwind U4/U6 snRNA or a second 
dsRNA unrelated to splicing6. Strikingly, Brr2 in the presence of ten fold molar excess Prp8 
was able to fully unwind the U4/U6 snRNA duplex within 30 minutes at 30°C (Fig. 3B). 
Similar stimulation was also observed with an equimolar Brr2 to Prp8-CTF ratio (25nM 
Brr2 and Prp8-CTF with 200nM U4/U6, data not shown). It is notable that because these 
reaction conditions include 8-fold excess of U4/U6 snRNA (200nm) over Brr2 (25nM), 
multiple turnover events per enzyme are required for the reactions to achieve completion. 
Prp8-CTF alone did not show any inherent helicase activity (Supplementary Fig. 2). 
Importantly, the unwinding activity is also dependent on a functional helicase domain in 
Brr2 since the Brr2-1 mutant protein was unable to unwind U4/U6 snRNAs (data not 
shown).
To assess the role of the RP region of Prp8-CTF in stimulating Brr2, we examined the effect 
of Prp8-CTF containing RP mutations on helicase activity. In particular, we highlight 
R2388G (Prp8-CTF-R2388G) because it demonstrated similar behavior to wild-type Prp8-
CTF in yield, purity, and stability during recombinant expression and purification. 
Interestingly, despite the fact that Prp8-CTF-R2388G retains some affinity for Brr2 (Fig. 
2B), Prp8-CTF-R2388G does not stimulate Brr2′s helicase activity (Figs. 3B,C). To further 
characterize whether this lack of stimulation is simply due to a lack of binding between 
Prp8-CTF-R2388G and Brr2, we titrated the amount of Prp8-CTF-R2388G present in the 
helicase assay. Significantly, we observed no additional unwinding with 80 fold molar 
excess of Prp8-CTF-R2388G (2.0μM) over Brr2 (25nM) (Fig. 3D). We also examined Prp8-
CTF fragments containing F2382L and R2388K in the helicase assay. Interestingly, in the 
case of these mutants, we observed ∼40% unwinding after 60 minutes, which is 
approximately twice the amount of unwinding as in the Brr2 alone condition, in the presence 
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of 10 fold molar excess of Prp8-CTF-F2382L(250nM) or 10 or 80 fold molar excess of 
Prp8-CTF-R2388K (250nM, 2.0μM) over Brr2 (25nM) (data not shown).
Brr2′s ATPase activity is modulated by Prp8-CTF
To gain insight into the mechanism of ATP-dependent unwinding activity by Brr2, we 
performed Brr2 ATPase assays in the presence and absence of Prp8-CTF. Using thin-layer 
chromatography (TLC), we measured the amount of inorganic phosphate released from 32P 
gamma labeled ATP as a function of time. Importantly, the buffer conditions and 
temperature used in the ATPase assays are identical to those examined in the unwinding 
assays (shown in Fig. 3). In Figure 4A, representative TLC panels of time courses are 
shown. Assays performed in the absence of RNA show that Brr2 is an RNA-dependent 
ATPase and indicate that the background level of hydrolysis observed for each of the protein 
components is quite low. From these experiments, we determined the rate of ATP hydrolysis 
per Brr2 per minute in the presence of U4/U6 (Fig. 4B). We found that Brr2 hydrolyzes one-
third as much ATP when Prp8-CTF is added to the reaction. To more fully characterize the 
Brr2 enzyme and Prp8-CTF co-factor relationship, we examined the RNA concentration 
dependence of Brr2 ATPase activity in the presence and absence of Prp8-CTF (Fig. 4C). 
Although the high RNA concentrations required prevent us from accurately assigning a Km 
value, we did observe a significant decrease in the ATP hydrolysis rate for all RNA 
concentrations examined in the presence of Prp8-CTF.
Interestingly, in the presence of Prp8-CTF-R2388G, Brr2 hydrolyzes an intermediate level 
of ATP in comparison to reactions with Prp8-CTF or no co-factor. This suggests that Prp8-
CTF-R2388G’s ability to weakly bind Brr2 is able to influence Brr2′s ability to hydrolyze 
ATP even though it shows no measurable effect on its unwinding ability. We further 
expanded this study to include other Prp8 RP mutations (Fig. 5). We observed a range of 
phenotypes for the RP mutations. Notably, F2382L, the mutation that retained the best 
ability to bind Brr2, showed no inhibitory effect on ATPase activity. R2388K showed the 
same ability to inhibit Brr2 as wild-type Prp8-CTF. Taken together with the findings of 
partial helicase stimulation by Prp8-CTF-R2388K and Prp8-CTF-F2382L, these findings 
suggest that Brr2 binding, stimulation of U4/U6 unwinding and inhibition of ATP hydrolysis 
are at least partially independent functions of the C terminal domain.
Discussion
Prp8 Modulates ATPase and Helicase Activities of Brr2
When base-paired with U4 snRNA in the context of the U4/U6.U5 triple snRNP, U6 snRNA 
is catalytically inert, a state which is promoted by the high stability of the U4/U6 duplex (Tm 
= 53°C in budding yeast)43. Unwinding of U4 by the Brr2 DExD/H-box helicase is 
presumably precisely timed in vivo to ensure that splicing signals have been accurately 
recognized. Because Brr2 is a stable component of the U5 snRNP, a fundamental question is 
how its activity is strictly controlled to maintain fidelity. Here we have employed a minimal 
biochemical system to demonstrate that the C-terminal ∼600 amino acids of the U5 snRNP 
protein Prp8 (Prp8-CTF) are required to activate Brr2 to unwind a synthetic U4/U6 duplex. 
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To our knowledge, this is the first report of a co-factor for a spliceosomal ATPase with a 
known in vivo target.
Importantly, the ability of the Prp8-CTF to stimulate U4/U6 unwinding is lost or 
substantially impaired if the protein carries prp8 alleles responsible for retinitis pigmentosa 
(RP) in humans. Recent ultrastructural analyses reveal that these mutants map to a 35 amino 
acid unstructured tail following a highly structured alpha helix extending from a compact 
core comprised of a Jab1/MPN domain28,29. These RP mutations inhibit the interaction of 
Brr2 with the Prp8-CTF to varying extents. This direct contact does not appear to be the 
only function of these residues, however, since increasing the concentrations of RP mutant 
Prp8-CTF does not lead to further helicase stimulation or ATPase activity inhibition. This 
suggests that binding between these mutants and Brr2 is near capacity.
An important issue for the future will be the location of the precise interaction site on Brr2. 
This question is particularly interesting in view of its unusual domain structure: an N-
terminal canonical DEIH-box domain, and a C-terminal non-consensus DDAH motif both 
flanked by regions of homology to Sec63. The brr2-1 allele lies in the N-terminal helicase 
domain20 and inactivates the ability of the protein to unwind U4/U6 in our assay confirming 
that helicase activity is due to Brr2. Previous two-hybrid studies suggest that the C-terminus 
of Prp8 contacts a region of the second helicase motif, specifically amino acids 1301 to 1816 
in human Brr2 (ref. 28), in which case the stimulatory effect on unwinding is likely to be via 
an allosteric mechanism.
Although the Prp8-CTF stimulates the helicase activity of Brr2, it strongly inhibits the 
RNA-dependent ATPase activity. Because the unregulated ATPase levels are high in this in 
vitro system, an attractive hypothesis is that one function of Prp8 is to couple ATP 
hydrolysis to productive unwinding events in vivo. Repression of a basal ATPase level by a 
co-factor which stimulates helicase activity has been observed previously for both a DNA 
helicase, DnaB, and its co-factor, SSB44 as well the RNA helicase NS3 and its co-factor 
NS5b45, although the mechanisms by which the co-factor modulates the coupling of ATP 
hydrolysis and helicase activity remain unknown. From studies of other DExD/H-box 
proteins, it has been suggested that the conformational changes consequent to ATP 
hydrolysis are relayed via motifs III and VI to motifs IV and V, which are involved in RNA 
binding2,3,46,47. The hypothesis that Prp8-CTF acts to couple ATPase and helicase 
activities is consistent with the observation that several RP alleles that are defective in 
unwinding also show a reduction in inhibition. Nonetheless, overall there is no consistent 
correlation between Brr2 interaction, stimulation of U4/U6 unwinding, and inhibition of 
ATP hydrolysis. Thus more work is needed to understand the relationships of these three 
biochemical activities to one another.
A related question is how the U4/U6 RNA substrate is recognized. To address the possibility 
that Prp8 stimulates the unwinding reaction by increasing Brr2′s affinity for RNA, as has 
been seen for other DExD/H-box proteins48,49, we assayed Brr2 activity as a function of 
U4/U6 concentration. However, we were unable to calculate a Km for either the ATPase or 
helicase activities, since we could not achieve saturating levels of RNA. Presumably in the 
context of the spliceosome, the high local concentration of reactants obviates the need for 
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high intrinsic affinities. Another mechanism by which Prp8 might influence the U4/U6 
unwinding function of Brr2 is by increasing the processivity of the reaction, either by direct 
interaction with the helicase or indirectly through the interaction with nucleic acid by 
trapping the single stranded nucleic acid allowing for continued unwinding of the duplex50. 
In particular, such a mechanism might be warranted by the length and strength of U4/U6 
stem II, the most stable duplex in the spliceosome. Interestingly, it has been suggested that 
Prp43′s processivity is affected by Ntr1, its protein co-factor10. Experiments are in progress 
to further characterize the properties of the current system, including monitoring 
processivity per se.
Retinitis pigmentosa and splicing
Human Prp8 (RP13) is one of four splicing factors encoded by genes associated with 
autosomal dominant alleles of RP31,51. Prp3 (RP11) and Prp31 (RP18) are also tri-snRNP 
proteins, and PAP-1 (RP9) is a negative splicing regulator that binds Prp3 (refs. 52,53). 
Previous reports have suggested that reduced level of tri-snRNPs might be responsible for 
the retinal phenotype (reviewed in ref. 31), yet our results point to one more interesting 
possibility, namely the disregulation of catalytic activation. In particular, Prp3 is known to 
bind to U4/U6 stem II54 and Brr2-dependent unwinding disrupts this binding site, 
displacing Prp3 from the spliceosome. Thus the Prp3-U4/U6 interaction may likely 
antagonize Brr2 activity. The known sites of RP alleles in Prp3 lie outside its RNA-binding 
domain55. Conceivably they identify sites of interaction that, like Prp8, modulate the 
activity of Brr2. Overall, this disregulation of catalytic activation may result in broadly 
decreased splicing efficiency in photoreceptor cells that have high demands on the splicing 
machinery, resulting in cell death31. Conversely, the RP phenotype could be due to 
transcript-specific effects in these cells 56,57.
A Model for Splicing Regulation
Our findings are contrary to previous genetic studies that suggested that Prp8 negatively 
regulates Brr2-dependent unwinding39,40. In fact, we do not rule out that Prp8 may act as 
both a positive and negative regulator of Brr2. Indeed, our conclusion that the C-terminal 
region of Prp8 regulates the activation of the Brr2 helicase presupposes a mechanism by 
which the Prp8-Brr2 interaction is itself regulated. Recent evidence suggests several levels 
at which such control is likely to be effected. Staley and Sontheimer uncovered a regulatory 
mechanism, namely that the activity of Brr2 is negatively regulated by ubiquitination of 
Prp8 (ref. 58). While the site of modification on Prp8 is currently unknown, it is tempting to 
speculate that ubiquitin is recognized intramolecularly by interaction with the Jab1/MPN 
domain and that this association precludes the Brr2-Prp8-CTF interaction. Interestingly, the 
importance of this region is further evidenced by our preliminary result that a truncated form 
of Prp8-CTF containing only the last ∼300 amino acids is sufficient to stimulate Brr2′s 
helicase activity (Maeder, Kutach, Guthrie, unpublished data).
Finally, it has been shown by Staley and colleagues that Brr2 not only controls the 
dissociation of U4 from U6 at the beginning of the splicing cycle, but also the dissociation 
of U2 and U6 during spliceosome disassembly23. In both cases, Brr2 activity is inhibited by 
the binding of Snu114 to GDP; indeed the spliceosomal GTPase appears to function akin to 
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G proteins, as a conformational switch whose activity depends on the identify of the bound 
nucleotide23. While in principle the control of Brr2 activity by Snu114 could be direct, it is 
interesting to note that both the ATPase and the GTPase interact with the same C-terminal 
region of Prp8 (refs. 28,29). Since extensive genetic evidence supports a role for Snu114 in 
the function of Prp8 (ref. 59), an attractive hypothesis is that the nucleotide state of Snu114 
controls a conformational rearrangement of Prp8, which in turn modulates the availability of 
the C-terminus for interaction with Brr2. Important questions that can be addressed using 
our minimal system include determining whether the Prp8-CTF also promotes Brr2-
depending unwinding of U2 and U6, and whether helicase activity is inhibited by Prp8 
ubiquitination.
Materials and Methods
Growth assays
Strains for growth assays were created by transforming the parent strain yTB72 (MAT a, 
lys2D, ura3D, leu2D, his3D, prp8::LYS2, pJU169: PRP8, URA3)59 with PRP8-harboring 
plasmids, and then subjected to selection on 5-fluoroorotic acid (5-FOA)-containing media 
to counter select against the PRP8 and URA3-marked plasmid pJU169. The final strains 
were verified to be uracil auxotrophs confirming the absence of plasmid pJU169. 
Construction of the mutant plasmids is described in the Supplementary Methods and 
Supplementary Table 1. Oligonucleotides used in plasmid constructions are listed in 
Supplementary Table 2.
Growth assays were performed by growing yeast strains in YP + 2% (w/v) glucose liquid 
growth medium (YPD) overnight at 20°C. The cells were diluted to 0.1 OD600 in liquid 
YPD and continued to grow for approximately 5 hours. The cultures were then diluted to 
0.05 OD600 in liquid YPD and 5-fold serially diluted. Approximately 5 μl of each strain 
were deposited onto replicate YPD agar medium and incubated at 20°C (five days), 30°C (2 
days), or 37°C (2 days).
RNA synthesis, purification, and duplex annealing
U4 and U6 snRNA were synthesized from run-off transcriptions from pT7U4 (ref. 60) and 
pT7U6 (ref. 41) linearized with Sty1 and Dra1 respectively using T7 RNA polymerase. Syn 
U6 containing 22-116 nt of U6 snRNA was synthesized by Dharmacon. All RNAs were 
purified by extraction from a 6% (w/v) TBE polyacrylamide gel, phenol:chloroform 
extraction, and ethanol precipitation. U4/U6 duplex was made fresh from every experiment. 
RNAs were combined in 15mM HEPES pH 7.9 and 400 mM NaCl and heated to 75°C for 5 
min. MgCl2(10mM) was added immediately once the RNA sample was removed from 
heating. Samples were cooled at room temperature for 30 min. In the case of the helicase 
assays, duplex formation was driven by using excess synU6 (1.5 fold over U4). In the case 
of the ATPase assay, duplex formation was driven by using excess U4 (1.5 fold over U6). 
Concentrations indicated are that of the duplex.
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Protein expression and purification
BL21-DE3 Rosetta cells (Novagen) were transformed with inducible T7 expression 
plasmids (pDEST15 (Invitrogen)). 500 ml cultures were grown at 37°C to OD600 of 0.4, 
diluted with 500 ml 4°C LB medium, incubated 15 minutes at 16°C, and induced with 
0.4mM IPTG. Cells were harvested after 16 hours and then frozen. To purify GST-Prp8-
CTFs, frozen cell pellets were thawed in 30 ml of buffer (20mM Hepes 7.9, 300mM NaCl, 
1mM BME, 0.2mM EDTA, 1mM Benzamidine, 0.05% (v/v) Np-40, 0.5mM PMSF, 2μg 
ml-1 Pepstatin A), and disrupted by microfluidization (Microfluidics). Lysates were clarified 
by centrifugation, 0.45μm filtration, and adsorbed to a 0.5 ml glutathione-Sepharose (GE) 
resin bed. The resins were washed with five 10-column volume washes of extraction buffer, 
and eluted in extraction buffer plus 10 mM reduced glutathione. The eluted proteins were 
dialyzed twice against 2 liters of storage buffer (20mM Hepes 7.9, 100mM NaCl, 1mM 
BME, 0.2mM EDTA, 1mM Benzamidine, 0.01% (v/v) Np-40, and 20% (v/v) glycerol) and 
flash frozen in liquid N2. Constructions of bacterial expression plasmids are described in the 
Supplementary Methods. Prp8-CTF and mutant concentrations were determined using 
calculated extinction coefficient, 122535 M-1cm-1.
The TAP-tagged Brr2 overexpression plasmid, pGPD-BRR2-TAP (Gift from Scott Stevens) 
was shuffled into yeast strain yTB105 (ref. 59). Six liters of culture were grown to OD600 of 
3 in YPD liquid medium. Cells were processed and purified following the TAP protocol37 
with the following exceptions: the soluble extract was supplemented to 750 mM NaCl prior 
to the first affinity step, and in some preparations, a ball mill was used to homogenize the 
frozen cell paste in place of a mortar and pestle. The final purified protein was dialyzed 
twice for two hours against 20mM Hepes, 100mM NaCl, 5mM BME, 1mM Benzamidine, 
0.01% (v/v) Np-40, 20% (v/v) glycerol. The purified Brr2 protein retains the C-terminally 
fused calmodulin-binding domain. Brr2-CBP concentrations were determined using 
calculated extinction coefficient, 252,000 M-1cm-1.
GST pull down assays
Purified GST-Prp8-CTF fusions (20 pmol) were bound to glutathione-Sepharose (5 μL) for 
20 min. The resins were pelleted and washed with 1 ml of binding buffer (20mM Hepes 7.9, 
100mM NaCl, 1mM BME, 0.2mM EDTA, 0.01% (v/v) Np-40). The GST-Prp8-CTF-bound 
resins were incubated with 20 ul of 1μM Brr2 protein for 30 min with rocking. The resins 
were pelletted, unbound proteins aspirated, and washed twice with binding buffer (1 mL). 
The proteins bound to the resins were eluted by boiling in 20 μl of reducing SDS-loading 
dye and resolved by SDS-PAGE. Western blotting was used to detect GST-CTF and Brr2-
CBP. Secondary antibodies were IR800 labeled anti-rabbit IgG that permitted detection with 
an Odyssey imager (Li-COR). Quantification was performed with the manufacturer’s 
provided software for band intensity integration. Percent Brr2 bound was calculated by 
using the following equation: (((Brr2mutant-GST)/Prp8-CTFmutant)/((Brr2WT-GST)/Prp8-
CTFWT))*100.
Helicase assays
The reaction mixtures (10uL) contained 64mM NaCl, 30 mM Tris pH7, 2.5mM MgCl2, 
1.5mM DTT, 600ng uL-1 BSA, 20U RNasin (Roche) with 25 nM Brr2 and 250 nM GST-
Maeder et al. Page 10
Nat Struct Mol Biol. Author manuscript; available in PMC 2009 July 08.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Prp8-CTF or GST-Prp8-RP. Trace amounts of HEPES, NP-40 and EDTA are present in the 
reactions. U4/U6 snRNAs were incubated in the reaction mixture for 5 min at 30°C before 
initiating unwinding reactions with 2mM ATP. Reactions were performed at 30°C. Aliquots 
(1 uL) were withdrawn at time points and terminated with 19uL of stop solution (20mM 
EDTA, 0.2M NaCl, 1% (w/v) SDS). Time point samples (2uL) were annealed with 100fmol 
of Alexa Fluor 647 labeled oligo 14B (5′-AGGTATTCCAAAAATTCCC-3′ which is 
complementary to U4 positions 140 to 158)42 for 15 min at 42°C. A zero time point sample 
was boiled for 2 minutes to indicate free U4. Unwound U4 and U6 were separated from 
duplexed U4/U6 on a 9% (w/v) native gel42. The amount of U4/U6 and U4 were quantified 
on an Odyssey imager (Li-Cor). The percentage unwinding was calculated as follows: 
(counts for free U4/(counts for free U4+counts for U4/U6))*100.
ATPase assays
All ATPase assays were performed under identical conditions to the helicase assays with the 
following exceptions: [γ-32P]ATP was combined with cold ATP to make a total of 2mM in 
the reaction. RNA and ATP were combined separately from the remainder of the reaction 
mixture, and both mixtures were incubated for 5 min at 30°C. Reactions were initiated by 
combining RNA/ATP with the reminder of the reaction. Aliquots (1uL) were withdrawn and 
terminated with 2uL of 0.5M EDTA. Time-point samples (1uL) were spotted on to 
cellulose-PEI TLC plates (JT Baker), which was developed with 0.1M KPO4 pH7.4 buffer. 
The amount of ATP hydrolyzed was quantified using a Storm phosphoimager. The 
percentage hydrolyzed was calculated as follows: (counts for Pi/ (counts for Pi+counts for 
ATP))*100 for each time point. Percentage ATP hydrolyzed was plotted against time to 
determine a rate of hydrolysis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
A C-terminal fragment of Prp8 was able to directly interact with Brr2. (a) Schematic 
diagram of full-length yeast Prp8 and the C-terminal fragment of Prp8 (Prp8-CTF) used in 
this study. Yeast two-hybrid interactions with Brr2 (1-163; 2010-2413 aa)33 and Snu114 
(420-770, 2239-2335 aa 27-29 previously described are indicated as rectangles with their 
amino acid location noted. The NLS (96-156 aa) and RRM (1059-1151 aa) are noted26. The 
RNase H domain with protruding β-finger domain (1833-1990 aa)34-36 and Jab1/MPN 
domain (2178-2310 aa)26 and RP mutants used in this study are noted on the Prp8-CTF 
diagram. (b) GST-tagged Prp8-CTF interacted equally well with CBP (calmodulin binding 
protein)-tagged Brr2 or CBP-tagged Brr2-1 at incubation together for 10 minutes and 
isolation on glutathione resin. The Western blot was performed detecting for GST and CBP.
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Figure 2. 
Retinitis pigmentosa mutants of Prp8 have variable effects on growth and ability of Prp8 to 
bind Brr2. (a) Growth phenotypes of PRP8 retinitis pigmentosa mutants. Serial dilutions of 
cells spotted onto YPD agar plates and photographed after 5 days growing at 20°C, or two 
days at 30 or 37°C. (b) GST-tagged Prp8-CTF mutants have varied ability to bind Brr2. 
Western blotting detects for GST and CBP. Detection of the wild-type Prp8-CTF signal is 
saturated in order to be able to see the weaker binding of the RP mutants. GST alone with 
Brr2 is shown to indicate the non-specific binding present. % Brr2 bound is indicated below 
the gel (see Materials and Methods). Dashed line indicates non-relevant lanes that are not 
shown.
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Figure 3. 
Unwinding of U4/U6 by Brr2 is stimulated by addition of Prp8-CTF. (a) Schematic diagram 
of the ATP-dependent Brr2-catalyzed unwinding of duplexed U4/U6 snRNAs. The grey 
portion of U6 snRNA is present in full-length U6 snRNA, but absent from U6syn 
synthesized RNA. (b) Native gel analysis of a time course of unwinding of U4/U6 (200nM) 
by Brr2 (σ, 25nM) shows that Brr2 was stimulated by the addition of Prp8-CTF (○, 250nM) 
but not by Prp8-CTF-R2388G (■, 250nM). B indicates an aliquot of the reaction boiled. A 
fluorescently labeled oligo was used to detect U4 snRNA on both U4/U6 duplex or free U4. 
Native gel analysis was performed on the aliquots. (c) Graphical representation of the 
unwinding of U4/U6 snRNAs in the presence of Prp8-CTF or Prp8-CTF-R2388G shown in 
(b). The values are average of three independent experiments ; error bars indicate s.d. (d) 
Unwinding assay of U4/U6 duplex in which increasing amounts of Prp8-R2388G are used in 
the reaction indicates that additional Prp8-CTF-R2388G did not result in stimulation of 
Brr2. Assays were performed as described in (b) with the exception that the amount of Prp8-
CTF-R2388G was changed for each lane. Thirty minute time points are shown for reactions 
with 25nM, 50nM, 125nM, 250nM, 500nM, 750nM, 1μM, and 2μM Prp8-CTF-R2388G. S 
indicates the amount of U4/U6 unwind at time=0. B indicates an aliquot of the reaction 
boiled.
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Figure 4. 
ATPase activity of RNA-dependent Brr2 is inhibited by Prp8-CTF. (a) Time courses of 
ATPase activity assays for Brr2 (25nM) in the absence or presence of Prp8-CTF (250nM) or 
Prp8-CTF-R2388G (250nM) with 1μM U4/U6 duplex showed that Brr2′s ATPase activity is 
inhibited by Prp8-CTF. Reaction time points were taken at 0, 4, 8, 12, and 16 minutes. (b) 
Average ATPase activities obtained from three to five independent experiments similar to 
(a). Error bars indicate s.e.m. A paired t-test determined that the difference between Brr2 
alone and Brr2 with Prp8-CTF-R2388G is significant (p= 0.0256). (c) RNA concentration 
dependence of Brr2′s ATPase activity in the presence (■) or absence (○) of Prp8-CTF is 
shown. Duplicate data sets are shown, and the best fit curves are derived from the combined 
data sets.
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Figure 5. 
ATPase activity of RNA-dependent Brr2 is affected differently by RP mutations. ATPase 
activity assays for Brr2 (25nM) in the presence of Prp8-CTF (250nM) or Prp8-CTF mutants 
(250nM) with 1μM U4/U6 duplex. The molar ratio of Prp8-CTF to Brr2 is indicated. 
Average ATPase activities obtained from three independent experiments. Error bars indicate 
s.e.m.
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